SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,744.40 1,443.00
( 1.87%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

62,088.48 -993.38
(-1.57%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.604918

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

42.18

81.05

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

sanwaria consumer ltd

Ultracab (India) standalone net profit declines 37.06% in the June 2026 quarter

Aug 13,2026

Net profit of Ultracab (India) declined 37.06% to Rs 1.07 crore in the quarter ended June 2026 as against Rs 1.70 crore during the previous quarter ended June 2025. Sales rose 31.98% to Rs 79.36 crore in the quarter ended June 2026 as against Rs 60.13 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	79.36	60.13	32
OPM %	3.62	6.00	-
PBDT	1.82	2.72	-33
PBT	1.42	2.35	-40
NP	1.07	1.70	-37

78,744.40 1,443.00 ( 1.87%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

62,088.48 -993.38 (-1.57%)

10,852.07 213.64 (2.01%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)